EXCLUSIVE PATENT LICENSE AGREEMENT by and between MERCK, SHARP & DOHME CORPORATION and TARGENICS, Inc.Exclusive Patent License Agreement • December 29th, 2017 • ARMO BioSciences, Inc. • Pharmaceutical preparations • New York
THIS EXCLUSIVE PATENT LICENSE AGREEMENT (this “Agreement”), dated as of December 12, 2012 (the “Effective Date”), is by and between Merck, Sharp & Dohme Corporation, a corporation organized and existing under the laws of New Jersey (hereinafter referred to as “Merck”), and Targenics, Inc., a corporation organized and existing under the laws of Delaware (hereinafter referred to as “Licensee”). Merck and Licensee are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
March 19, 2016 Gail Brown, MD Re: Employment Offer; Employment Agreement Dear Gail:Employment Agreement • December 29th, 2017 • ARMO BioSciences, Inc. • Pharmaceutical preparations • California
On behalf of ARMO BioSciences (the “Company”), I am very excited to offer you the position of Chief Medical Officer (CMO). Speaking for myself, as well as the Company’s Board of Directors (the “Board”), we are looking forward to work with you and to the skills you will bring to the Company. We believe that with your background, you will make significant contributions to the success of the Company.
ARMO BIOSCIENCES, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT August 11, 2017Investors’ Rights Agreement • December 29th, 2017 • ARMO BioSciences, Inc. • Pharmaceutical preparations • California
This AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (the “Agreement”) is made as of the 11th day of August, 2017, by and among ARMO BIOSCIENCES, INC., a Delaware corporation (the “Company”), and the investors listed on Schedule A hereto, each of which is herein referred to as an “Investor” and collectively as the “Investors.
ARMO BIOSCIENCESEmployment Agreement • December 29th, 2017 • ARMO BioSciences, Inc. • Pharmaceutical preparations
On behalf of ARMO BioSciences (the “Company”), I am very excited to offer you the position of President and Chief Executive Officer (CEO). Speaking for myself, as well as the Company’s Board of Directors (the “Board”), we are looking forward to work with you and to the skills you will bring to the Company. We believe that with your background, you will make significant contributions to the success of the Company.
ARMO BIOSCIENCESEmployment Agreement • December 29th, 2017 • ARMO BioSciences, Inc. • Pharmaceutical preparations
ARMO BIOSCIENCESEmployment Agreement • December 29th, 2017 • ARMO BioSciences, Inc. • Pharmaceutical preparations • California
LEASE BETWEEN METROPOLITAN LIFE INSURANCE COMPANY (LANDLORD) AND ARMO BIOSCIENCES, INC. (TENANT) SEAPORT CENTER Redwood City, CaliforniaLease Agreement • December 29th, 2017 • ARMO BioSciences, Inc. • Pharmaceutical preparations • California
FIRST AMENDMENT TO LEASELease • December 29th, 2017 • ARMO BioSciences, Inc. • Pharmaceutical preparations
This First Amendment to Lease (“Amendment”) is entered into, and dated for reference purposes, as of October 14, 2016 (the “Execution Date”) by and between METROPOLITAN LIFE INSURANCE COMPANY, a New York corporation (“Landlord”), and ARMO BIOSCIENCES, INC., a Delaware corporation (“Tenant), with reference to the following facts (“Recitals”):
